SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Melnyk Peter M. (Last) (First) (Middle) C/O NOVOCURE INC., 20 VALLEY STREAM PKWY SUITE 300 (Street) MALVERN PA 19355 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 10/01/2015	3. Issuer Name and Ticker or Trading Symbol Novocure Ltd [ NVCR ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Commercial Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options to Buy Ordinary Shares	(1)	09/15/2021	Ordinary Shares	76,869	$3.44	D
Options to Buy Ordinary Shares	(1)	09/15/2021	Ordinary Shares	16,260	$6.72	D
Options to Buy Ordinary Shares	(2)	02/20/2023	Ordinary Shares	41,391	$7.03	D
Options to Buy Ordinary Shares	(3)	02/26/2024	Ordinary Shares	59,130	$7.48	D
Options to Buy Ordinary Shares	(4)	02/25/2025	Ordinary Shares	177,390	$14.37	D

Explanation of Responses:

1. Fully vested and currently exercisable as of the date hereof.

2. Options to buy 20,695 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 20,696 ordinary shares will vest and become exercisable in equal installments on each of February 20, 2016 and 2017, subject to Mr. Melnyk's continued employment through such dates.

3. Options to buy 14,782 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 44,348 ordinary shares will vest and become exercisable in equal installments on each of February 26, 2016, 2017 and 2018, subject to Mr. Melnyk's continued employment through such dates.

4. The options to buy 177,390 ordinary shares will vest and become exercisable in equal installments on each of February 25, 2016, 2017, 2018 and 2019, subject to Mr. Melnyk's continued employment through such dates.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Todd Longsworth, Attorney in fact for Peter Melnyk	10/01/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.